Base Therapeutics is a pioneering biotechnology company specializing in high-fidelity gene editing technologies and immune cell therapies, particularly focused on cancer treatment
Base Therapeutics is a pioneering biotechnology company specializing in high-fidelity gene editing technologies and immune cell therapies, particularly focused on cancer treatment. The company has developed the AccuBase® base editing system, which allows for precise gene modifications without off-target effects, and is advancing its BASE-NK and BEAT-CART product pipelines.